Prescriber's Letter | Unbiased Medication Updates & CME

December 2024 Issue

Give More Adults a Pneumococcal Vaccine

We’re getting lots of questions about pneumococcal vaccines for adults...

Resources

Algorithm: Pneumococcal Vaccination in Adults

Tackle Ongoing GLP-1 Agonist Questions

Questions continue to pour in about GLP-1 agonists (semaglutide, etc)...

Be Aware of the Medicare Prescription Payment Plan

Questions are swirling about the new Medicare Prescription Payment Plan (MPPP)...

Don’t Rush to Aprocitentan for Resistant Hypertension

Aprocitentan (Tryvio) will be the first dual endothelin antagonist approved for resistant hypertension...

GO TO FULL ISSUE

CE & Training

NEW REQUIRED COURSE: Substance Use Disorders and Pain Management: MATE Act Training

CE-IN-THE-LETTER: Prescriber Insights December 2024

LIVE CE: Immunization Updates 2024: Discussing Your Big Questions

PODCAST CE: Medication Talk - Immunization Updates 2024

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Prescriber's Letter?

Prescriber's Letter is the fastest, most trustworthy way to find out how drug therapy changes should fit into your practice, all while earning monthly CME credit. It's 100% free from financial support of the pharma industry. Learn more >

Unlock More

Prescriber's Letter is one of many medication advisory, CE, and training solutions from TRC Healthcare. We support prescribers of all kinds, at all stages of their career.

If you're a training decision-maker, learn more about our:

Solutions for Group Practices
Patient Simulations to Standardize Clinical Practice

Group Purchases & Pricing

Prescriber's Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information